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BACKGROUND: Bronchiectasis is one of the major health 
problems in Ethiopia. We analyzed the outcome of surgery done for 
bronchiectasis in a resource-limited setup.                         
METHODS: A retrospective cross-sectional analysis of 22 patients 
who underwent surgery for bronchiectasis in Tikur Anbessa 
specialized hospital (TASH) during the period 2012 - 2017 were 
done. 
 RESULTS: There were 13(59%) female and 9(41%) male patients 
with a mean age of 34.1 +/-16.9 years. The mean duration of 
symptoms was 2.2 years. Blood streak sputum, 13(59%), dyspnea, 
9(49.9%), fetid sputum, 8(36.4%), dry cough, 6(27.3%), chest pain, 
6(27.3%) and massive hemoptysis 3(13.6%) were the main 
presenting symptoms. In 20(91%) of the patients, previous history 
of TB treatment was identified. Recurrent childhood infection, 
1(4.5%), and tumor obstruction, 1(4.5%), were also seen. 
Bronchiectasis  was left sided in 12(54.5%), right-sided in 7(31.8%) 
and bilateral in 3(13.6%) patients. The disease affected multiple 
lung lobes in 9(40.9%), left lower lobe in 6(27.3%) and left upper 
lobe in 3(13.6%) cases. Indications for surgery were the failure of 
medical management in 10(45.5%), destroyed lung in 9(40.9%), 
and massive hemoptysis in 3(13.6%) cases. The procedures 
performed were lobectomy in 14(63.6%) and pneumonectomy in 
8(36.4%) cases. Postoperative complications occurred in 5(22.7%) 
patients with one (4.5%) death. On the other hand, 77.3% of 
operated patients had significant improvement compared to their 
preoperative symptoms.  
CONCLUSIONS: In a resource-limited setup like TASH, localized 
bronchiectasis can be treated surgically with an acceptable result. 
Proper selection and preparation with complete resection of the 
involved segments are needed for maximum control of symptoms 
and better outcomes.  
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Bronchiectasis, originally described by René 
Laënnec in 1819, is a suppurative lung disease 
characterized by permanent dilatations of bronchi 
with the destruction of the bronchial wall (1). 
Before the antibiotic era, the disease was 
considered a morbid disease with high mortality 
from respiratory failure and corpulmonale (2). The 
clinical picture differs greatly and may involve 
repeated respiratory infections with chronic 
production of sputum (2,3,5). Today, with the 
improvement of healthcare and the availability of 
suitable antibiotics, the prevalence of 
bronchiectasis has declined (4). In developed 
countries, patients with early disease can be 
treated successfully by conservative procedures 
(5,7). However, in developing countries like 
Ethiopia, bronchiectasis still constitutes an 
important problem because of tuberculosis, 
pneumonia, and pertussis (13). Current reports 
from developed countries about the surgical 
management for bronchiectasis show that limited 
localized disease was associated with good 
postoperative prognosis (2-11). 
The objective of this study was to look into 
the surgical outcome of bronchiectasis in Tikur 
Anbessa Specialized Hospital (TASH) within a 
resource-limited situation. Its presentation, 
etiology, diagnostic tools, indications for surgery, 
surgical approach, and the outcome was analyzed.  
 
PATIENTS AND METHODS  
 
We retrospectively reviewed the medical records 
of 22 patients who underwent surgical resection 
for bronchiectasis between March 2012 and March 
2017, at the Department of Cardiothoracic Surgery 
in Tikur Anbessa Specialized Hospital. Variables 
of age, sex, symptoms, etiology, involved lobe, 
indications and types of surgery, mortality, 
morbidity, and the results of surgical therapy were 
analyzed. Most patients were referred for surgery 
by their pulmonologist after long-term medical 
treatment, and some were admitted from our 
outpatient clinic as a referral from other hospitals. 
Preoperative assessment included clinical history, 
physical examination, Chest Radiography (CXR), 
computed tomography of the chest, and 
pulmonary function tests for selected patients. 
Surgical treatment was considered when the 
symptoms persisted despite repeated courses of 
antibiotic treatment and if the extent of the 
diseased lung is localized to achieve complete 
resection. Surgery was also considered in cases 
with imaging features of destroyed lobe or lung. 
non-surgical treatments included the use of 
appropriate antibiotic, postural drainage, and 
bronchodilators. Symptoms that justify operations 
were recurrent pneumonia and/or recurrent 
hemoptysis. 
A double-lumen endotracheal tube was used 
to minimize contralateral contamination of the 
lung with secretions. A posterolateral thoracotomy 
was used for all patients. Complete resection is 
defined as an anatomic resection of all affected 
segments that were assessed preoperatively by 
computed tomography. If the affected part of the 
lung is limited to one lobe, lobectomy was done 
and when the whole lung was affected, 
pneumonectomy was performed. Using a 
polypropylene suture in two layers, the bronchial 
stumps were closed. 
Postoperative management included chest 
physiotherapy and administration of antibiotics 
and analgesics. Operative mortality included 
patients who died within 30 days after surgery or 
those who died later but during the same 
hospitalization.  
All patients were followed up in our OPD. 
The clinical outcome of surgery was assessed by  
asking the patients to describe their current status 
in comparison to their preoperative condition. All 
data were stored using SPSS version 22.0 for 
Windows. Clinical data on different variables 
were reported as mean or ranges. When it is 





A total of 22 patients who underwent surgical 
treatment for bronchiectasis in our department 
were included in this study. The mean age of these 
patients was 34.1±16.9 years (range of 14 to 64 
years). The female-to-male ratio was 13/9 where 
59.1% of the patients were female. 
All patients were symptomatic. The most 
common presenting symptom was blood streak 
sputum which occurred in 13(59%) of patients.  
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Copious amount of fetid sputum was found in 
8(36.4%) patients, shortness of breath in 9(49.9%), 
and chest pain in 6(27.3%) patients. The mean 
duration of symptoms was 2.2 years (ranged of 6 
months to 6 years). All patients had previous medical 
therapy and follow-up before admission. 
Postero-anterior and lateral chest X-ray and CT 
scan were done for all patients. Diagnosis of 
bronchiectasis was based primarily on the chest CT 
scan finding. It determines the type and extent of 
bronchiectasis (Figure 1). The disease was on the left 
side in 12(54.5%) patients, in the right side in 
7(31.8%), and bilateral in 3(13.6%) patients. 
Bronchiectasis involvement was multi-lobar in 
9(40.9%) patients, predominantly in the lower lobes. 
The left lower lobe was affected in 6(27.3%) and the 
right lower lobe in 2(9.1%) patients (Table 1). 
 
Table 1: Demographic characteristics, symptoms, 
causes, affected side and site of bronchiectasis. 
The indications for pulmonary resection were 
the failure of medical therapy in 10(45.5%), 
destroyed lung in 9(40.9%), and recurrent or 
massive hemoptysis in 3(15.9%) cases. 
Posterolateral thoracotomy complete resections of 
all diseased segments were performed in all 
patients. Fourteen (63.6%) patients had lobectomy 
and 8(36.4%) patients had pneumonectomy. 
Complications occurred in 5(22.7%) patients 
and included postoperative atelectasis requiring 
bronchoscopy in 1(4.5%) patient, pneumonia in 
2(9.1%) patients, and bronchopleural fistula in 
2(9.1%) patients. Operative mortality was seen in 
1(4.5%) patients. The median hospital stay was 17 
days (range of 8 to 54 days). 
Follow-up data were obtained from all 
patients in the study. The symptoms disappeared 
in 17(77.3%) patients; 2(9.1%) patients showed 
residual symptoms, and 1(4.5%) patient died due 
to a postop medical complication. 
 
Table 2: Indication, type and complication of 
surgery done for patients with Bronchiectasis. 
 
 
Variables No (%) 
Indications for surgery   
Failure of medical 
management 
10 (45.5) 
Destroyed lung 9 (40.9) 
Massive hemoptysis 3 (15.9) 
Surgery done  
Lobectomy 14 (63.6) 
Pneumonectomy 8 (36.4) 
Complications  
Atelectasis 1 (4.5) 
Pneumonia 2 (9.1) 
Bronchopleural fistula 2 (9.1) 










Variables                                                 No. (%) 
  Age (mean+/-SD) years 
  Sex  
         - Male 
         - Female 
 Symptoms 
          - Fetid sputum 
          - Shortness of breath 
          - Chest pain 
          - Blood streak sputum 
          - Dry cough 
 Causes of Bronchiectasis 
          - TB 
          - Recurrent childhood infection 
          - Tumor obstruction 
Affected side 
          - Left 
          - Right 
          - Bilateral 
Affected Lobe 
          - Left lower lobe 
          - Left upper lobe 
          - Right lower lobe 
          - Right upper lobe 
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Figure 1:  CT Scan of the chest that shows right 




Bronchiectasis is pathologically defined as a 
condition in which there are abnormal and 
permanent dilatations of proximal bronchi (2). The 
cause for the bronchiectatic changes could be 
ending result of tuberculosis, bronchial obstruction 
due to sequestration, and foreign body or tumor 
(2-7). Before the antibiotic era, the disease was 
considered a morbid one with a high mortality rate 
from respiratory failure and corpulmonale (7,19).  
The incidence of bronchiectasis in Ethiopia is 
still unknown. However, from our clinical 
observation, it is still high. In developed countries, 
studies showed that its prevalence is currently 
decreasing because of the proper use of 
antimicrobial therapy and immunization against 
viral agents (2-10).  
The optimal treatment for bronchiectasis still 
remains controversial (7). In cases of foreign 
body, early recognition and removal using 
Bronchoscope to minimize the subsequent 
development of bronchiectatic changes (6). 
Different literatures reported different causes 
of bronchiectasis including Post TB, bronchial 
obstruction with either foreign body or tumor, 
immune deficiency, impaired mucocilinary 
clearance, inflammatory pneumonitis, structural 
airways abnormalities and association with other 
diseases (2-7). Other studies also reported that the 
cause is unknown in a significantly high 
percentage of patients ranging from 26% to 53% 
(9,16).  
Khaled et al (16) reported that predisposing 
factor was identified in only 35% of cases 
(predominately previous TB infection). In our 
study, post TB bronchial stenosis was the most 
common cause. All patients have history of 
treatment for pulmonary TB. They were all treated 
for 6 months to 6 years before they are admitted 
for surgery of bronchiectasis. 
The typical presentation of patients with 
bronchiectasis is productive cough, recurrent 
pulmonary infections, bronchial suppuration, and 
purulent bronchorrhea (3). Similar to our series, 
blood streak sputum, cough, and fetid sputum are 
the most common symptoms in other series too (4-
9). Out of 166 patients, Kutlay et al (9) reported 
that cough was reported in all patients; purulent 
sputum in 135, fetid sputum in 109 and 
hemoptysis was seen in 35 patients.   
Bronchiectasis is basically diagnosed with a 
clinical history and CT scan findings. CT criteria 
for the diagnosis of bronchiectasis are well 
established which is an internal diameter of the 
bronchus more than 1.5 times than that of 
accompanying artery and evidence of lack of 
tapering of bronchi (11). 
The most dependent portions of the lung that 
includes posterior basal portions of the lower 
lobes, middle lobe, and lingula are the primary 
sites for bronchiectasis. Generally, one-third of 
bronchiectasis is unilateral and affects a single 
lobe, one third is unilateral but affects more than 
one lobe, and one third is bilateral (2,3). In our 
series, the disease affected the left lung in 
12(54.5%) patients. It was mainly confined to the 
lower lobes either alone in 6(27.3%) or in 
conjunction with other lobes in 9(40.9%) patients.  
Bronchiectasis should be treated initially with 
conservative management. Preventing recurrent 
infection, bronchodilator and chest physiotherapy 
(postural drainage) are the main components of 
conservative treatment. If conservative medical 
management is not successful or frequent episodes 
of hemoptysis exist, surgical therapy should be 
considered (7,19). As was the case with other 
series, the indications for surgeries in our study 
were the failure of medical therapy, destroyed 
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lung, and recurrent hemoptysis in descending 
order (12-17). 
The primary objectives of surgical 
intervention for bronchiectasis are to improve the 
quality of life, treat or prevent complications like 
empyema, recurrent hemoptysis, and lung abscess 
(7,9,14). Because bronchiectasis is a progressive 
disease, the affected segment of the lung should be 
resected with an intention of preserving the 
uninvolved lung parenchyma. To achieve this 
goal, early surgery, while the disease is still 
localized, is preferred. In order to minimize 
cardiorespiratory failure, the aim of surgery 
should be complete resection with maximum 
preservation of lung function. Therefore, every 
type of resection is possible for these purposes. 
Ultimately, in order to ensure adequate lung 
function, a minimum of two lobes or six 
pulmonary segments must be spared. For 
successful surgery, Kutlay et al recommend that 
the operation should be performed in a ‘dry 
period’ (9). 
Apart from the eight patients who underwent 
pneumonectomy for destroyed lung, most of our 
patients had a localized disease to one or more 
lobe. In selected patients with bilateral 
bronchiectasis, surgical therapy can be considered 
as one option of treatment. In our series, 2(9.1%) 
patients were operated on bilateral bronchiectasis. 
Complication occurrence is 9.4-24.6% in the 
current literature. Therefore, our result of (22.7%) 
is within the reported incidence (2-19). It included 
early and late complications such as prolonged air 
leak of more than 14 days, atelectasis, pneumonia, 
and bronchopleural fistula. Mortality ranges from 
0% to 8.3% in the literature, and current mortality 
is less than 1% (2-20). 
  In our study, there was one (4.5%) death. The 
patient was a 47-year-old male for whom the left 
upper lobectomy was done for an indication of 
post-tuberculosis bronchiectasis. The patient was 
doing well until postoperative day 3 when he 
started to have shortness of breath. He was found 
to be in respiratory distress with a respiratory rate 
of 35 breaths per minute, pulse rate of 108 beats 
per minute, and oxygen saturation of 65-70%. 
There was decreased air entry over the lower two-
thirds of the left lung field. He had ECG and 
echocardiographic features of pulmonary 
embolism. The patient was transferred to the ICU 
the same day, and he was put on mechanical 
ventilator and anticoagulants. However, he passed 
away on a post-operative day 6 with immediate 
cause of death irespiratory failure secondary to 
massive pulmonary embolism.  
In conclusion, even though the follow-up 
time was short, we did not compare the variation 
in exercise tolerance test and the changes in 
spirometry values; the overall patient assessment 
following surgery can be considered to have a 
satisfactory outcome. Similar with other studies, 
more than 77% of our the patients had a complete 
relief of their preoperative symptoms. For 
localized disease, with surgical treatment of 
bronchiectasis, our patients could obtain 
satisfactory results with acceptable morbidity and 
mortality.  
Finally, we recommend that patients should 
continue their OPD follow-up visit for longer 
period, as assessment for recurrence requires 
many years of follow-up study. Proper patient 
selection and preparation with complete resection 
of the involved sites are needed for the optimum 
control of symptoms and better outcomes. As the 
number of cases operated on bronchiectasis is 
limited, awareness creation among physicians 
working in Ethiopia about the availability of 
surgical option for treatment of localized 
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